Fennec Pharmaceuticals Inc. (NASDAQ: FENC)
$6.1900
N/A ( +0.65% ) 44.1K
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Market Data
Open
$6.1900
Previous close
$6.1900
Volume
44.1K
Market cap
$169.81M
Day range
$5.9610 - $6.2750
52 week range
$3.9600 - $11.9200
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Aug 19, 2024 |
| 10-q | Quarterly Reports | 62 | Aug 13, 2024 |
| 8-k | 8K-related | 17 | Aug 07, 2024 |
| 4 | Insider transactions | 1 | Aug 01, 2024 |
| 4 | Insider transactions | 1 | Aug 01, 2024 |
| 4 | Insider transactions | 1 | Jul 08, 2024 |
| 8-k | 8K-related | 16 | Jul 02, 2024 |
| 4 | Insider transactions | 1 | Jul 02, 2024 |
| 4 | Insider transactions | 1 | Jul 02, 2024 |
| 8-k | 8K-related | 13 | Jun 25, 2024 |